Allison Zavitz

Allison Zavitz is a seasoned Global Lifecycle Leader in Oncology, specializing in lung driver mutations, with a strong background in commercialization, development, and strategy within the pharmaceutical industry. They held pivotal roles at EMD Serono Canada and Roche, managing teams with full P&L responsibility and leading significant product launches. Their education includes a B.P.H.E. and B.Sc. in Biology from Queen's University, an MBA from McMaster University, and ongoing studies in Biopharma at London Business School. Driven by a patient-focused approach, Allison empowers cross-functional teams to achieve results through collaboration and strategic execution.